Normal view MARC view ISBD view

Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus. [electronic resource]

By:

Chung, Yuan Chiang

Contributor(s):

Producer: 20110324Description: 84-92 p. digitalISSN:

1872-7298

Subject(s):

Online resources:

Available from publisher's website

In: Gene expression patterns : GEP vol. 11

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1221 The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis.
by Potts, Jessica E
1222 GLP-1 Receptor Mediated Targeting of a Fluorescent Zn(2+) Sensor to Beta Cell Surface for Imaging Insulin/Zn(2+) Release.
by Li, Daliang
1223 Glucagon-like peptide-1(7-36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cells.
by Gallwitz, B
1224 Presence of glucagon and glucagon-like peptide-1-(7-36)amide receptors in solubilized membranes of human adipose tissue.
by Mérida, E
1225 Small introns in a hepatic cDNA encoding a new glucagon-like peptide 1-type receptor.
by Svoboda, M
1226 Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
by Runge, S
1227 High-level expression of the GLP-I receptor results in receptor desensitization.
by Fehmann, H C
1228 Physiology of GLP-1--lessons from glucoincretin receptor knockout mice.
by Thorens, B
1229 Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs.
by Driessen, Johanna H M
1230 Selectivity of peptide ligands for the human incretin receptors expressed in HEK-293 cells.
by Al-Sabah, S
1231 Evolving directions in obesity management.
by Aronne, Louis J
1232 The regions within the N-terminus critical for human glucagon like peptide-1 receptor (hGLP-1R) cell surface expression.
by Thompson, Aiysha
1233 Expression of the glucagon like peptide-1 receptor in human pancreas and incretin therapy.
by Teitelman, Gladys
1234 Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial.
by Miya, Aika
1235 Insulin Glargine/Lixisenatide: A Review in Type 2 Diabetes.
by Scott, Lesley J
1236 Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysis.
by Zaccardi, Francesco
1237 [Dulaglutide (Trulicity®), a new once-weekly agonist of glucagon-like peptide-1 receptors for type 2 diabetes].
by Scheen, A J
1238 Development of novel ligands for peptide GPCRs.
by Moran, Brian M
1239 Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus.
by Hanefeld, Markolf
1240 Pancreatic alpha cells in diabetic rats express active GLP-1 receptor: Endosomal co-localization of GLP-1/GLP-1R complex functioning through intra-islet paracrine mechanism.
by Nakashima, Koji